APR 28, 2015
Tell FDA Compounding Regulation Would Interfere with AMD and Other Treatment Options
The Academy is urging ophthalmologists to tell the FDA that its proposal on pharmaceutical compounding and beyond-use dates would interfere with the ability to care for patients.